compound glp 1 ban Compounded Weight Loss Medication Facts About Compounded GLP-1 Drugs
Description
Tirzepatide, the first dual GIP/GLP-1 receptor co-agonist approved for type 2 diabetes in the USA, Europe, and the UAE, targets both appetite and glucose control
Why the caveats: Most human data is observational, not randomized controlled trials designed to prove prevents dementia. So far, we cannot definitively say GLP-1 RAs prevent Alzheimers
by Rina Thibault, Holistic Wellness Practitioner
Here's what FDA approvals, ADA guidelines and recent trials actually say.
This is a year-over-year improvement of 30 percentage points, almost doubling after three years
